MENU
+Compare
CRLBF
Stock ticker: OTC
AS OF
Nov 13 closing price
Price
$1.07
Change
-$0.09 (-7.76%)
Capitalization
382.65M

CRLBF Cresco Labs Inc. Forecast, Technical & Fundamental Analysis

Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs’ national dispensary brand and others... Show more

CRLBF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for CRLBF with price predictions
Nov 12, 2025

CRLBF's Stochastic Oscillator ascends into overbought zone

The Stochastic Oscillator for CRLBF moved into overbought territory on November 12, 2025. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 12, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CRLBF as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

CRLBF moved below its 50-day moving average on November 12, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CRLBF crossed bearishly below the 50-day moving average on October 29, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRLBF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CRLBF entered a downward trend on November 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CRLBF just turned positive on November 12, 2025. Looking at past instances where CRLBF's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where CRLBF advanced for three days, in of 242 cases, the price rose further within the following month. The odds of a continued upward trend are .

CRLBF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CRLBF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.893) is normal, around the industry mean (18.827). P/E Ratio (0.000) is within average values for comparable stocks, (71.764). CRLBF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.856). CRLBF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (0.562) is also within normal values, averaging (39.291).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRLBF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
CRLBF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

CRLBF is expected to report earnings to fall 56.55% to -2 cents per share on March 18

Cresco Labs Inc. CRLBF Stock Earnings Reports
Q4'25
Est.
$-0.02
Q3'25
Missed
by $0.03
Q2'25
Missed
by $0.01
Q1'25
Missed
by $0.01
Q3'24
Missed
by $0.03
The last earnings report on November 05 showed earnings per share of -5 cents, missing the estimate of -2 cents. With 446.47K shares outstanding, the current market capitalization sits at 382.65M.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
400 West Erie Street
Phone
+1 312 319-8442
Employees
3200
Web
https://www.crescolabs.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGRTX86.170.27
+0.31%
JPMorgan US Value R2
DGOCX28.290.05
+0.18%
Davis Opportunity C
EMQAX10.03N/A
N/A
Ashmore Emerging Markets Active Eq A
DWOAX21.84-0.02
-0.09%
BNY Mellon Research Growth A
MPSSX22.07-0.03
-0.14%
BNY Mellon Small Cap Multi-Strategy M

CRLBF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CRLBF has been closely correlated with TSNDF. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRLBF jumps, then TSNDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRLBF
1D Price
Change %
CRLBF100%
-4.13%
TSNDF - CRLBF
76%
Closely correlated
-8.59%
CURLF - CRLBF
76%
Closely correlated
-1.42%
TCNNF - CRLBF
75%
Closely correlated
-0.86%
JUSHF - CRLBF
74%
Closely correlated
-10.77%
GTBIF - CRLBF
72%
Closely correlated
-3.45%
More

Groups containing CRLBF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRLBF
1D Price
Change %
CRLBF100%
-4.13%
Pharmaceuticals: Generic
industry (214 stocks)
23%
Poorly correlated
-1.00%